Fidelity Investments’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Fidelity Investments’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-150,447	Closed	-$739K	–	2785
2016 Q4	$739K	Sell	150,447 -1,664,695	-92%	-$8.52M	﹤0.01%	2508
2016 Q3	$9M	Sell	1,815,142 -92,524	-5%	-$474K	﹤0.01%	2027
2016 Q2	$9.71M	Hold	1,907,666	–	–	﹤0.01%	1981
2016 Q1	$10.9M	Sell	1,907,666 -163,300	-8%	-$1.14M	﹤0.01%	1924
2015 Q4	$21.5M	Hold	2,070,966	–	–	﹤0.01%	1656
2015 Q3	$38.3M	Hold	2,070,966	–	–	0.01%	1362
2015 Q2	$40.3M	Hold	2,070,966	–	–	0.01%	1433
2015 Q1	$36.4M	Hold	2,070,966	–	–	﹤0.01%	1475
2014 Q4	$33.1M	Hold	2,070,966	–	–	﹤0.01%	1518
2014 Q3	$26.1M	Hold	2,070,966	–	–	﹤0.01%	1629
2014 Q2	$32.3M	Sell	2,070,966 -168,200	-8%	-$2.47M	﹤0.01%	1568
2014 Q1	$29.4M	Hold	2,239,166	–	–	﹤0.01%	1586
2013 Q4	$36M	Hold	2,239,166	–	–	0.01%	1469
2013 Q3	$37.3M	Buy	2,239,166 +1,321,446	+144%	+$19.5M	0.01%	1421
2013 Q2	$9.24M	Buy	+917,720	New	+$9.64M	﹤0.01%	1954

Other funds holding OSIR

HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Fidelity Investments's OSIR Position: Q1 2017 in Review

Fidelity Investments sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 150,447 shares — an estimated $739K sold.

Fidelity Investments first reported a position in OSIR in Q2 2013 and held it in 15 quarters. The position peaked at $40.3M in Q2 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

Fidelity Investments reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
Fidelity Investments sold 150,447 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $739K.
Fidelity Investments first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 15 quarters.
Fidelity Investments's Osiris Therapeutics, Inc. Common Stock position peaked at $40.3M in Q2 2015.
11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Fidelity Investments's 13F filing for Q1 2017, filed 11 May 2017.